S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$5.79
-1.9%
$4.30
$2.84
$11.50
$315.79M2.364.68 million shs6.30 million shs
3D Systems Co. stock logo
DDD
3D Systems
$3.39
-2.6%
$4.54
$3.38
$11.09
$452.33M1.751.67 million shs1.54 million shs
37 Capital Inc stock logo
JJJ
37 Capital
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
$8.25
-0.2%
$11.06
$8.10
$12.74
$309.14MN/A172,765 shs146,909 shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-6.05%-7.16%+85.53%+32.94%-9.15%
3D Systems Co. stock logo
DDD
3D Systems
-1.27%-16.02%-23.41%-25.85%-63.04%
37 Capital Inc stock logo
JJJ
37 Capital
0.00%0.00%0.00%0.00%0.00%
Metagenomi, Inc. stock logo
MGX
Metagenomi
-3.16%-20.63%-18.44%+826,999,900.00%+826,999,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
3D Systems Co. stock logo
DDD
3D Systems
2.3911 of 5 stars
3.01.00.02.21.11.70.6
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/AN/AN/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
2.2374 of 5 stars
4.50.00.00.00.61.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.00
BuyN/AN/A
3D Systems Co. stock logo
DDD
3D Systems
2.00
Hold$7.25113.86% Upside
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
3.00
Buy$21.40159.39% Upside

Current Analyst Ratings

Latest MGX, JJJ, DDD, AJC, and ACB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/28/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$21.00
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$22.00
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$16.00
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$23.00
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$21.00
3/5/2024
Metagenomi, Inc. stock logo
MGX
Metagenomi
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$25.00
2/13/2024
3D Systems Co. stock logo
DDD
3D Systems
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$8.50
2/9/2024
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
(Data available from 4/17/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$174.88M1.81N/AN/AN/A
3D Systems Co. stock logo
DDD
3D Systems
$488.07M0.93N/AN/A$3.14 per share1.08
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
$44.76M6.91N/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$799.22M-$2.90N/AN/AN/A-48.82%-23.27%-15.75%6/12/2024 (Estimated)
3D Systems Co. stock logo
DDD
3D Systems
-$370.43M-$2.84N/AN/AN/A-75.90%-9.34%-4.56%5/13/2024 (Estimated)
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
-$68.25MN/A0.00N/AN/AN/AN/AN/A6/26/2024 (Estimated)

Latest MGX, JJJ, DDD, AJC, and ACB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
2/27/2024Q4 2023
3D Systems Co. stock logo
DDD
3D Systems
-$0.07-$0.17-$0.10$1.96$124.33 million$114.85 million
2/8/2024Q3 2024
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$0.10-$0.20-$0.10N/A$45.94 million$53.34 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
3D Systems Co. stock logo
DDD
3D Systems
N/AN/AN/AN/AN/A
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.14
3.79
2.45
3D Systems Co. stock logo
DDD
3D Systems
0.76
4.30
3.24
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
N/A
4.04
4.04

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
3D Systems Co. stock logo
DDD
3D Systems
64.49%
37 Capital Inc stock logo
JJJ
37 Capital
N/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
N/A

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
3D Systems Co. stock logo
DDD
3D Systems
3.18%
37 Capital Inc stock logo
JJJ
37 Capital
N/A
Metagenomi, Inc. stock logo
MGX
Metagenomi
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,13054.54 million54.53 millionOptionable
3D Systems Co. stock logo
DDD
3D Systems
2,032133.43 million129.19 millionOptionable
37 Capital Inc stock logo
JJJ
37 Capital
N/AN/AN/ANot Optionable
Metagenomi, Inc. stock logo
MGX
Metagenomi
23637.47 millionN/AN/A

MGX, JJJ, DDD, AJC, and ACB Headlines

SourceHeadline
Metagenomi to Present at Upcoming Scientific MeetingsMetagenomi to Present at Upcoming Scientific Meetings
globenewswire.com - April 8 at 8:00 AM
Metagenomi, Inc. Expected to Earn FY2024 Earnings of ($2.44) Per Share (NASDAQ:MGX)Metagenomi, Inc. Expected to Earn FY2024 Earnings of ($2.44) Per Share (NASDAQ:MGX)
marketbeat.com - April 4 at 9:14 AM
Metagenomi (NASDAQ: MGX)Metagenomi (NASDAQ: MGX)
fool.com - April 3 at 3:54 AM
Metagenomi Inc MGXMetagenomi Inc MGX
morningstar.com - April 2 at 5:53 PM
Metagenomi, Inc.: Strong Buy Rating on Robust Hemophilia Program and Strategic PartnershipsMetagenomi, Inc.: Strong Buy Rating on Robust Hemophilia Program and Strategic Partnerships
markets.businessinsider.com - March 29 at 4:47 AM
Metagenomi, Inc.: Strong Buy Rating on Promising Pipeline and Solid Financial PositioningMetagenomi, Inc.: Strong Buy Rating on Promising Pipeline and Solid Financial Positioning
markets.businessinsider.com - March 29 at 4:47 AM
Metagenomi, Inc.: Metagenomi Reports Business Updates and Full Year 2023 Financial ResultsMetagenomi, Inc.: Metagenomi Reports Business Updates and Full Year 2023 Financial Results
finanznachrichten.de - March 28 at 6:44 PM
Metagenomi (NASDAQ:MGX) Stock Rating Reaffirmed by Chardan CapitalMetagenomi (NASDAQ:MGX) Stock Rating Reaffirmed by Chardan Capital
marketbeat.com - March 28 at 8:28 AM
Metagenomi reports FY resultsMetagenomi reports FY results
msn.com - March 27 at 12:31 PM
Metagenomi Reports Business Updates and Full Year 2023 Financial ResultsMetagenomi Reports Business Updates and Full Year 2023 Financial Results
globenewswire.com - March 27 at 9:16 AM
Metagenomi to Participate in the 44th Annual Cowen Healthcare ConferenceMetagenomi to Participate in the 44th Annual Cowen Healthcare Conference
globenewswire.com - February 29 at 4:30 PM
This Biotech IPO Stock Just Took a Tumble, But Dont Give Up on It YetThis Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet
fool.com - February 19 at 10:30 AM
Insider Buying: Taking a Controlling Stake in a Struggling Retailer?Insider Buying: Taking a Controlling Stake in a Struggling Retailer?
247wallst.com - February 18 at 11:20 AM
Metagenomi Announces Closing of Initial Public OfferingMetagenomi Announces Closing of Initial Public Offering
globenewswire.com - February 13 at 4:35 PM
Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debutModerna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut
reuters.com - February 9 at 2:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aurora Cannabis logo

Aurora Cannabis

NASDAQ:ACB
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
3D Systems logo

3D Systems

NYSE:DDD
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
37 Capital logo

37 Capital

CNSX:JJJ
37 Capital Inc., a junior mineral exploration company, engages in the acquisition, exploration, and development of natural resource properties in Canada. The company has a 33% interest in the Extra High property located to the northeast of Kamloops, British Columbia. It also has royalty interests in various lithium mineral properties located in the Province of Ontario. The company was formerly known as High 5 Ventures Inc. and changed its name to 37 Capital Inc. in July 2014. 37 Capital Inc. was incorporated in 1984 and is based in Vancouver, Canada. 37 Capital Inc. is a subsidiary of Jackpot Digital Inc.
Metagenomi logo

Metagenomi

NASDAQ:MGX
Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.